Hippocampal gene expression of deiodinases 2 and 3 and effects of 3,5-diiodo-L-thyronine T2 in mouse depression paradigms

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Markova, Natalyia ^a   Chernopiatko, Anton ^b   Schroeter, Careen A ^c   Malin, Dmitry ^d,e   Kubatiev, Aslan ^e   Bachurin, Sergey ^a   Costa Nunes, João ^f,g   Steinbusch, Harry M W ^f   Strekalova, Tatyana ^c,f,g  

^a INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^b Timantti AB   (Sweden)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF WISCONSIN   (United States)

^e INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

3,5-DIIODOTHYRONINE; DIIODOTHYRONINE; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE II; IODOTHYRONINE DEIODINASE TYPE III; LIOTHYRONINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; DEPRESSION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; METABOLISM; MITOCHONDRION; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DEPRESSIVE DISORDER; DIIODOTHYRONINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; IODIDE PEROXIDASE; MICE; MITOCHONDRIA; SIGNAL TRANSDUCTION; TRIIODOTHYRONINE;

EID: 84893736136     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/565218     Document Type: Article

References (49)

1. Pinna G., Brödel O., Visser T., Jeitner A., Grau H., Eravci M., Meinhold H., Baumgartner A., Concentrations of seven iodothyronine metabolites in brain regions and the liver of the adu (Pubitemid 34415894)
2. Pinna G., Broedel O., Eravci M., Stoltenburg-Didinger G., Plueckhan H., Fuxius S., Meinhold H., Baumgartner A., Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation. Biological Psychiatry 2003 54 10 1049 1059 2-s2.0-0242559022 10.1016/S0006-3223(03)00414-1 (Pubitemid 37415040)
3. Guadaño-Ferraz A., Obregón M. J., St Germain D. L., Bernal J., The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proceedings of the National Academy of Sciences of the United States of America 1997 94 19 10391 10396 2-s2.0-0030928654 10.1073/pnas.94.19.10391 (Pubitemid 27407052)
4. Obregón M. J., de Ona C. R., Calvo R., del Rey F. E., Morreale de Escobar G., Outer ring iodothyronine deiodinases and thyroid hormone economy: responses to iodine deficiency in the rat fetus and neonate. Endocrinology 1991 129 5 2663 2673 2-s2.0-0025887559
5. 2). Biochemistry 2005 70 2 164 172 2-s2.0-17144398854 10.1007/s10541-005-0097-0 (Pubitemid 40512324)
6. Joffe R. T., Is the thyroid still important in major depression? Journal of Psychiatry and Neuroscience 2006 31 6 367 368 2-s2.0-33751400320 (Pubitemid 44815327)
7. Trentin A. G., Thyroid hormone and astrocyte morphogenesis. Journal of Endocrinology 2006 189 2 189 197 2-s2.0-33646764917 10.1677/joe.1.06680
8. Desouza L. A., Ladiwala U., Daniel S. M., Agashe S., Vaidya R. A., Vaidya V. A., Thyroid hormone regulates hippocampal neurogenesis in the adult rat brain. Molecular and Cellular Neuroscience 2005 29 3 414 426 2-s2.0-20444381661 10.1016/j.mcn.2005.03.010 (Pubitemid 40799214)
9. Giordano T., Pan J. B., Casuto D., Watanabe S., Arneric S. P., Thyroid hormone regulation of NGF, NT-3 and BDNF RNA in the adult rat brain. Molecular Brain Research 1992 16 3-4 239 245 2-s2.0-0027052363 10.1016/0169-328X(92)90231- Y (Pubitemid 23035966)
10. Moreau X., Jeanningros R., Majjola-Pomietto P., Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT1A and 5-HT2A receptors in adult rat brain. Neuropsychopharmacology 2001 24 6 652 662 2-s2.0-0035013379 10.1016/S0893-133X(00)00234-7 (Pubitemid 32452213)
11. Vaidya V. A., Castro M. E., Pei Q., Sprakes M. E., Grahame-Smith D. G., Influence of thyroid hormone on 5-HT(1A) and 5-HT(2A) receptor-mediated regulation of hippocampal BDNF mRNA expression. Neuropharmacology 2001 40 1 48 56 2-s2.0-0033764183 10.1016/S0028-3908(00)00094-0 (Pubitemid 33779799)
12. Cleare A. J., McGregor A., O'Keane V., Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clinical Endocrinology 1995 43 6 713 719 2-s2.0-0029590243 (Pubitemid 26016802)
13. Abraham G., Milev R., Stuart Lawson J., T3 augmentation of SSRI resistant depression. Journal of Affective Disorders 2006 91 2-3 211 215 2-s2.0-33644998292 10.1016/j.jad.2006.01.013
14. Bauer M., Heinz A., Whybrow P. C., Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Molecular Psychiatry 2002 7 2 140 156 2-s2.0-0036181205 10.1038/sj/mp/4000963 (Pubitemid 34177782)
15. Eravci M., Pinna G., Meinhold H., Baumgartner A., Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain. Endocrinology 2000 141 3 1027 1040 2-s2.0-0034455252 10.1210/en.141.3.1027 (Pubitemid 32266070)
16. Antonelli A., Fallahi P., Ferrari S. M., Di Domenicantonio A., Moreno M., Lanni A., Goglia F., 3,5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects. Journal of Biological Regulators and Homeostatic Agents 2011 25 4 655 660 2-s2.0-84856020533
17. de Lange P., Cioffi F., Senese R., Moreno M., Lombardi A., Silvestri E., de Matteis R., Lionetti L., Mollica M. P., Goglia F., Lanni A., Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats. Diabetes 2011 60 11 2730 2739 2-s2.0-80755184749 10.2337/db11-0207
18. Moreno M., Silvestri E., de Matteis R., de Lange P., Lombardi A., Glinni D., Senese R., Cioffi F., Salzano A. M., Scaloni A., Lanni A., Goglia F., 3,5-diiodo-L-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. The FASEB Journal 2011 25 10 3312 3324 2-s2.0-80053913540 10.1096/fj.11-181982
19. Rezin G. T., Amboni G., Zugno A. I., Quevedo J., Streck E. L., Mitochondrial dysfunction and psychiatric disorders. Neurochemical Research 2009 34 6 1021 1029 2-s2.0-64249162752 10.1007/s11064-008-9865-8
20. Lombardi A., Lanni A., Moreno M., Brand M. D., Goglia F., Effect of 3,5-di-iodo-L-thyronine on the mitochondrial energy-transduction apparatus. Biochemical Journal 1998 330, part 1 521 526 2-s2.0-0032519709 (Pubitemid 28075782)
21. Lanni A., Moreno M., Cioffi M., Goglia F., Effect of 3,3′-di- iodothyronine and 3,5-di-iodothyronine on rat liver mitochondria. Journal of Endocrinology 1993 136 1 59 64 2-s2.0-0027395439 (Pubitemid 23016114)
22. 2+ ]i elevations induced by iodothyronines (T3 and T2) in pituitary GH3 cells. The American Journal of Physiology-Endocrinology and Metabolism 2012 302 11 E1419 E1430
23. Ball S. G., Sokolov J., Chin W. W., 3,5-diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro. Journal of Molecular Endocrinology 1997 19 2 137 147 2-s2.0-0030744978 10.1677/jme.0.0190137 (Pubitemid 27431842)
24. Strum J. C., Shehee R., Virley D., Richardson J., Mattie M., Selley P., Ghosh S., Nock C., Saunders A., Roses A., Rosiglitazone induces mitochondrial biogenesis in mouse brain. Journal of Alzheimer's Disease 2007 11 1 45 51 2-s2.0-33847698158 (Pubitemid 46376708)
25. Zhao Y., Patzer A., Herdegen T., Gohlke P., Culman J., Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB Journal 2006 20 8 1162 1175 2-s2.0-33745983234 10.1096/fj.05-5007com (Pubitemid 44943912)
26. Eissa Ahmed A. A., Al-Rasheed N. M., Antidepressant-like effects of rosiglitazone, a PPAR γ agonist, in the rat forced swim and mouse tail suspension tests. Behavioural Pharmacology 2009 20 7 635 642 2-s2.0-70349667794 10.1097/FBP.0b013e328331b9bf
27. Rasgon N. L., Kenna H. A., Williams K. E., Powers B., Wroolie T., Schatzberg A. F., Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. TheScientificWorldJOURNAL 2010 10 321 328 2-s2.0-77749296286 10.1100/tsw.2010.32
28. Kemp D. E., Ismail-Beigi F., Ganocy S. J., Conroy C., Gao K., Obral S., Fein E., Findling R. L., Calabrese J. R., Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. Journal of Affective Disorders 2011 136 3 1164 1173 2-s2.0-84857367138 10.1016/j.jad.2011.06.033
29. Cline B. H., Steinbusch H. W., Malin D., The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2. BMC Neuroscience 2012 13, article 110
30. Strekalova T., Couch Y., Kholod N., Boyks M., Malin D., Leprince P., Steinbusch H. M. W., Update in the methodology of the chronic stress paradigm: internal control matters. Behavioral and Brain Functions 2011 7, article 9 2-s2.0-79955127404 10.1186/1744-9081-7-9
31. Strekalova T., Steinbusch H. M. W., Updated methodology of the chronic stress depression model: importance of internal control. Proceedings of the International Neuroscince Symposium of the Champalimaud Foundation September 2011 Lisbon, Portugal
32. Cryan J. F., Mombereau C., Vassout A., The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neuroscience and Biobehavioral Reviews 2005 29 4-5 571 625 2-s2.0-19944380200 10.1016/j.neubiorev.2005.03.009 (Pubitemid 40755457)
33. Moreno M., Lombardi A., Beneduce L., Silvestri E., Pinna G., Goglia F., Lanni A., Are the effects of T3 on resting metabolic rate in euthyroid rats entirely caused by T3 itself? Endocrinology 2002 143 2 504 510 2-s2.0-0036007226 10.1210/en.143.2.504 (Pubitemid 34107203)
34. Couch Y., Anthony D. C., Dolgov O., Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain, Behavior, and Immunity 2013 29 136 146
35. Strekalova T., Spanagel R., Bartsch D., Henn F. A., Gass P., Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 2004 29 11 2007 2017 2-s2.0-8444223161 10.1038/sj.npp.1300532 (Pubitemid 39486552)
36. Malatynska E., Steinbusch H. W., Redkozubova O., Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: implications for modeling elderly depression. Experimental Gerontology 2012 47 8 552 564
37. Pfaffl M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001 29 9, article e45 2-s2.0-17344392308
38. Vignisse J., Steinbusch H. W. M., Bolkunov A., Nunes J., Santos A. I., Grandfils C., Bachurin S., Strekalova T., Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 2 510 522 2-s2.0-79952901355 10.1016/j.pnpbp.2010.12.007
39. Strekalova T., Anthony D. C., Dolgov O., The differential effects of chronic imipramine or citalopram administration on physiological and behavioral outcomes in naïve mice. Behavioural Brain Research 2013 245 101 106
40. Willner P., Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005 52 2 90 110 2-s2.0-23844500078 10.1159/000087097 (Pubitemid 41160326)
41. Hamilton M., Development of a rating scale for primary depressive illness. The British Journal of Social and Clinical Psychology 1967 6 4 278 296 2-s2.0-0014186152
42. Harro J., Tonissaar M., Eller M., Kask A., Oreland L., Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry. Brain Research 2001 899 1-2 227 239 2-s2.0-0035957783 10.1016/S0006-8993(01)02256-9 (Pubitemid 32324164)
43. Strekalova T., Gorenkova N., Schunk E., Dolgov O., Bartsch D., Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behavioural Pharmacology 2006 17 3 271 287 2-s2.0-33645713909 10.1097/00008877-200605000-00008
44. Ibarguen-Vargas Y., Surget A., Vourc'h P., Leman S., Andres C. R., Gardier A. M., Belzung C., Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress. Behavioural Brain Research 2009 202 2 245 251 2-s2.0-67349123686 10.1016/j.bbr.2009.03.040
45. Galton V. A., Wood E. T., St Germain E. A., Withrow C.-A., Aldrich G., St Germain G. M., Clark A. S., St Germain D. L., Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development. Endocrinology 2007 148 7 3080 3088 2-s2.0-34347237311 10.1210/en.2006-1727 (Pubitemid 46997018)
46. Castillo M., Hall J. A., Correa-Medina M., Ueta C., Kang H. W., Cohen D. E., Bianco A. C., Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes 2011 60 4 1082 1089 2-s2.0-79953225879 10.2337/db10-0758
47. Friesema E. C., Ganguly S., Abdalla A., Manning Fox J. E., Halestrap A. P., Visser T. J., Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. The Journal of Biological Chemistry 2003 278 41 40128 40135 2-s2.0-0141891099 10.1074/jbc.M300909200 (Pubitemid 37248580)
48. Roberts L. M., Woodford K., Zhou M., Black D. S., Haggerty J. E., Tate E. H., Grindstaff K. K., Mengesha W., Raman C., Zerangue N., Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology 2008 149 12 6251 6261 2-s2.0-57349180438 10.1210/en.2008-0378
49. Schreiber G., Aldred A. R., Jaworowski A., Nilsson C., Achen M. G., Segal M. B., Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. The American Journal of Physiology 1990 258 2, part 2 R338 R345 2-s2.0-0025273055 (Pubitemid 20103238)